Patent · US Active

Transdermal delivery system for polynucleotides

US8041421B2 · kind B2 · utility

20Cited by
12References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 25, 2005
Grant dateOct 18, 2011
Priority date
Expiry dateDec 15, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A system for intradermal or transdermal delivery of oligonucleotides or polynucleotides and methods of use thereof employ an apparatus that generates micro-channels in the skin of a subject in conjunction with a pharmaceutical composition comprising an oligonucleotide or polynucleotide, wherein the oligonucleotide or polynucleotide can be delivered into the organism through the micro-channels. The system and methods achieve expression of target proteins encoded by the polynucleotides, and hence are useful in immunization and gene therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.